Compare OCUL & AGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OCUL | AGL |
|---|---|---|
| Founded | 2006 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Managed Health Care |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.0B |
| IPO Year | 2014 | 2021 |
| Metric | OCUL | AGL |
|---|---|---|
| Price | $8.64 | $103.97 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 12 |
| Target Price | $23.56 | ★ $55.68 |
| AVG Volume (30 Days) | ★ 2.3M | 321.3K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 2.94 |
| Revenue | $1,990,000.00 | ★ $5,932,576,000.00 |
| Revenue This Year | $7.93 | N/A |
| Revenue Next Year | $96.07 | $4.23 |
| P/E Ratio | ★ N/A | $34.11 |
| Revenue Growth | ★ 3.48 | N/A |
| 52 Week Low | $6.23 | $0.30 |
| 52 Week High | $16.44 | $133.04 |
| Indicator | OCUL | AGL |
|---|---|---|
| Relative Strength Index (RSI) | 37.85 | 48.39 |
| Support Level | $8.36 | $103.89 |
| Resistance Level | $9.93 | $125.71 |
| Average True Range (ATR) | 0.52 | 9.89 |
| MACD | -0.20 | -1.41 |
| Stochastic Oscillator | 0.00 | 22.01 |
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
Agilon Health Inc is a healthcare services company that partners with primary care physicians to support value-based care for senior patients. The company provides a platform that enables physician groups to manage healthcare outcomes and costs through a Medicare-centric, capitated care model and long-term partnerships with community-based physicians.